Cong Sun

1.5k total citations
47 papers, 737 citations indexed

About

Cong Sun is a scholar working on Oncology, Epidemiology and Infectious Diseases. According to data from OpenAlex, Cong Sun has authored 47 papers receiving a total of 737 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Oncology, 18 papers in Epidemiology and 10 papers in Infectious Diseases. Recurrent topics in Cong Sun's work include Viral-associated cancers and disorders (16 papers), Cytomegalovirus and herpesvirus research (12 papers) and SARS-CoV-2 and COVID-19 Research (6 papers). Cong Sun is often cited by papers focused on Viral-associated cancers and disorders (16 papers), Cytomegalovirus and herpesvirus research (12 papers) and SARS-CoV-2 and COVID-19 Research (6 papers). Cong Sun collaborates with scholars based in China, United States and United Kingdom. Cong Sun's co-authors include Mu‐Sheng Zeng, Chu Xie, Yinfeng Kang, Guo‐Long Bu, Zheng Liu, Xinchun Chen, Shumei Yan, Yanxin Wu, Wai‐Kit Ming and Xiang‐Wei Kong and has published in prestigious journals such as Advanced Materials, Nature Communications and SHILAP Revista de lepidopterología.

In The Last Decade

Cong Sun

46 papers receiving 725 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Cong Sun China 15 279 184 166 154 138 47 737
Chunyan He United States 15 198 0.7× 191 1.0× 103 0.6× 92 0.6× 107 0.8× 27 743
Wencheng Ding China 16 271 1.0× 645 3.5× 126 0.8× 158 1.0× 204 1.5× 55 1.2k
Mustafa Pehlıvan Türkiye 17 180 0.6× 219 1.2× 189 1.1× 82 0.5× 60 0.4× 117 867
Sara Jafarzadeh Iran 14 90 0.3× 220 1.2× 200 1.2× 78 0.5× 364 2.6× 26 843
Jiajia Jin China 16 140 0.5× 579 3.1× 208 1.3× 101 0.7× 70 0.5× 43 1.1k
Grant P. Parnell Australia 19 154 0.6× 276 1.5× 365 2.2× 211 1.4× 72 0.5× 38 914
Liheng Yang United States 12 92 0.3× 275 1.5× 142 0.9× 65 0.4× 55 0.4× 43 583
Xian Chen China 19 82 0.3× 387 2.1× 375 2.3× 113 0.7× 56 0.4× 64 1.1k
Lothar C. Fuith Austria 11 100 0.4× 215 1.2× 167 1.0× 116 0.8× 65 0.5× 33 762
Huiqin Li China 15 135 0.5× 209 1.1× 44 0.3× 108 0.7× 174 1.3× 46 664

Countries citing papers authored by Cong Sun

Since Specialization
Citations

This map shows the geographic impact of Cong Sun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cong Sun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cong Sun more than expected).

Fields of papers citing papers by Cong Sun

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cong Sun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cong Sun. The network helps show where Cong Sun may publish in the future.

Co-authorship network of co-authors of Cong Sun

This figure shows the co-authorship network connecting the top 25 collaborators of Cong Sun. A scholar is included among the top collaborators of Cong Sun based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cong Sun. Cong Sun is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sun, Cong, Guo‐Long Bu, Chu Xie, et al.. (2025). Structural basis of Epstein-Barr virus gp350 receptor recognition and neutralization. Cell Reports. 44(1). 115168–115168. 6 indexed citations
2.
Sun, Cong, Chu Xie, Dong‐Chun Hong, et al.. (2025). Chimeric Glycoprotein Nanoparticles Elicit Robust Neutralizing Antibodies Against Epstein–Barr Virus. Advanced Materials. 38(7). e07012–e07012. 1 indexed citations
3.
Sun, Cong, Lele Zhang, & Mu‐Sheng Zeng. (2025). Targeting EBV gp42 for nasopharyngeal carcinoma prevention. Molecular Therapy. 33(7). 2987–2989. 1 indexed citations
4.
Xie, Chu, Yuan-Tao Liu, Xiuchun Tian, et al.. (2025). Human herpesvirus 6B glycoprotein B postfusion structure, vulnerability mapping, and receptor recognition. PLoS Pathogens. 21(7). e1013300–e1013300. 1 indexed citations
6.
Yang, Jie, Qiao-Li Wang, Guannan Wang, et al.. (2024). A pan-KRAS degrader for the treatment of KRAS-mutant cancers. Cell Discovery. 10(1). 70–70. 8 indexed citations
7.
Zhao, Gexin, Guo‐Long Bu, Cong Sun, et al.. (2024). Potent human monoclonal antibodies targeting Epstein-Barr virus gp42 reveal vulnerable sites for virus infection. Cell Reports Medicine. 5(5). 101573–101573. 4 indexed citations
8.
Xie, Chu, Cong Sun, & Mu‐Sheng Zeng. (2024). Navigating Epstein–Barr virus autoimmunity: role of NK cells and T cells in multiple sclerosis. Signal Transduction and Targeted Therapy. 9(1). 48–48. 6 indexed citations
9.
Sun, Cong, Yan Wang, Yan Zeng, et al.. (2023). Neuropilin 1 is an entry receptor for KSHV infection of mesenchymal stem cell through TGFBR1/2-mediated macropinocytosis. Science Advances. 9(21). eadg1778–eadg1778. 20 indexed citations
10.
Sun, Cong, Chu Xie, & Mu‐Sheng Zeng. (2023). Breakthrough for Epstein-Barr virus vaccine development: gB nanoparticle vaccine. Chinese Science Bulletin (Chinese Version). 1 indexed citations
11.
Bu, Guo‐Long, Xiang‐Wei Kong, Cong Sun, et al.. (2023). mRNA‐based Vaccines Targeting the T‐cell Epitope‐rich Domain of Epstein Barr Virus Latent Proteins Elicit Robust Anti‐Tumor Immunity in Mice. Advanced Science. 10(35). e2302116–e2302116. 21 indexed citations
12.
Hong, Dong‐Chun, Jing Yang, Cong Sun, et al.. (2023). Genomic Profiling of Radiation-Induced Sarcomas Reveals the Immunologic Characteristics and Its Response to Immune Checkpoint Blockade. Clinical Cancer Research. 29(15). 2869–2884. 7 indexed citations
13.
Sun, Cong, Runyu Yuan, Chu Xie, et al.. (2022). Induction of Broadly Cross-Reactive Antibody Responses to SARS-CoV-2 Variants by S1 Nanoparticle Vaccines. Journal of Virology. 96(13). e0038322–e0038322. 4 indexed citations
14.
Zhu, Qian‐Ying, Sisi Shan, Jinfang Yu, et al.. (2021). A potent and protective human neutralizing antibody targeting a novel vulnerable site of Epstein-Barr virus. Nature Communications. 12(1). 6624–6624. 25 indexed citations
15.
Sun, Cong, Xinchun Chen, Yinfeng Kang, & Mu‐Sheng Zeng. (2021). The Status and Prospects of Epstein–Barr Virus Prophylactic Vaccine Development. Frontiers in Immunology. 12. 677027–677027. 30 indexed citations
16.
Zhang, Jiawen, et al.. (2020). Clinical relevance of ARF/ARL family genes and oncogenic function of ARL4C in endometrial cancer. Biomedicine & Pharmacotherapy. 125. 110000–110000. 10 indexed citations
17.
Wu, Yanxin, Cong Sun, Junyu Chen, et al.. (2020). Eliciting women’s preference for prenatal testing in China: a discrete choice experiment. BMC Pregnancy and Childbirth. 20(1). 604–604. 5 indexed citations
18.
Sun, Cong, et al.. (2020). Metformin Ameliorates Gestational Diabetes Mellitus-Induced Endothelial Dysfunction via Downregulation of p65 and Upregulation of Nrf2. Frontiers in Pharmacology. 11. 575390–575390. 25 indexed citations
19.
Wang, Li, Rui Zhang, Xiaohong Hou, et al.. (2019). DA-JC1 improves learning and memory by antagonizing Aβ31–35-induced circadian rhythm disorder. Molecular Brain. 12(1). 14–14. 19 indexed citations
20.
Ke, Zunfu, Yihao Liu, Yunjian Zhang, et al.. (2018). Diagnostic value and lymph node metastasis prediction of a custom‑made panel (thyroline) in thyroid cancer. Oncology Reports. 40(2). 659–668. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026